Altice USA announced that it will change its corporate name to Optimum Communications, effective November 7. The company will cease trading under ...

Follow all the latest U.S. market action for Thursday here as stocks struggle to recover bullish momentum as more investors question rich valuations.

XRP Treasury fitm Evernorth launches on Nasdaq under XRPN ticker after its $1 billion acquisition, signaling rising ...

Honeywell (NASDAQ: HON) today announced that it has completed the previously announced spin-off of its Advanced Materials business, now operating as Solstice Advanced Materials. Shares of Solstice ...

Armada Acquisition Corp. II, a special purpose acquisition company ("Armada II") sponsored by Arrington XRP Capital Fund, today announced ...

Public Limited Company (NASDAQ:SMX; SMXWW) (the "Company"), today announced that the reverse stock split of the Company's ordinary shares will begin trading on an adjusted basis ...

Adam Palasciano is a writer over three years of experience writing about personal finance, investing, student loans, and more, for outlets like GOBankingRates, FinanceBuzz, The Penny Hoarder, and Wall ...

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the ...

Hong Kong, Oct. 09, 2025 (GLOBE NEWSWIRE) -- SOLOWIN HOLDINGS (NASDAQ: SWIN) (“Solowin” or the “Company”), a leading financial services firm providing comprehensive solutions across traditional and ...

Canary Capital, a crypto-focused investment firm, has amended its SEC filings for spot Litecoin and HBAR ETFs with finalized ticker symbols and fee structures. The amendments come as Canary actively ...

Crypto infrastructure company reinforces its commitment to Solana stewardship and regional growth from its base in Abu Dhabi Shares will begin trading under the new ticker on October 3, 2025 ABU DHABI ...

Pfizer (NYSE:PFE) shares traded higher in the morning hours on Tuesday after The Washington Post reported that President Donald Trump is set to announce an agreement to offer the pharma giant’s drugs ...